跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22,666 条关于
“small molecule degraders”
全部
22,666
临床试验
13,718
药物
674
机构
127
资讯
8,147
去年
Kymera Therapeutics Raises $250.8 Million to Advance Targeted Protein Degradation Pipeline
去年
Engine Biosciences and EDDC Form Strategic Partnership to Develop Precision Cancer Therapies
2个月前
TRIMTECH Therapeutics Secures $14M Extension, Bringing Total Seed Round to $47M for Targeted Protein Degradation in Neurodegenerative Disease
去年
Therabene Appoints Dr. Oscar Kashala as CMO to Advance Protein Degrader Pipeline for Hard-to-Treat Cancers
7个月前
Ipsen Partners with Origami Therapeutics on Protein Degrader Program for Rare Neurodegenerative Diseases
9个月前
Kymera Therapeutics Closes Upsized $602 Million Public Offering to Advance Targeted Protein Degradation Pipeline
去年
Monte Rosa's AI-Powered Discovery Engine Expands Molecular Glue Degrader Target Space in Science Publication
2年前
AstraZeneca Unveils Oral Small Molecule PCSK9 Inhibitor AZD0780
去年
Monte Rosa Therapeutics Announces Key Milestones for Molecular Glue Degraders in 2025
去年
Inavolisib Triples Progression-Free Survival in Advanced Breast Cancer
第 1 页,共 815 页
上一页
下一页